New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 16, 2014
09:05 EDTBIOLBIOLASE CEO says 'absurd' Oracle claims must be addressed
BIOLASE CEO Federico Pignatelli stated, "I would prefer not to respond to [Oracle Partners'] absurd claims but their press release dated May 14, 2014 is an inappropriate attempt to mislead our stakeholders and accordingly it must be addressed." BIOLASE accuses Oracle of "blatantly trying to gain control" of the company's board and said that Oracle's lawsuit had a "dramatic and meaningful impact" on its end of quarter sales for the three months ended March 31. "I trust that the pending decision by the Chancery Court of Delaware will shed light on the true nature of Oracle's attempted takeover of BIOLASE. It is my firm belief that Oracle's lawsuit was an effort to disguise their ultimate goal to gain control of BIOLASE without paying the substantial premium that our stockholders deserve," said Pignatelli.
News For BIOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
16:11 EDTBIOLBIOLASE reports Q4 adjusted EPS (6c), consensus (4c)
Reports Q4 revenue $13.2M, consensus $14.9M.
March 2, 2015
06:02 EDTBIOLBIOLASE names David Dreyer CFO
BIOLASE announced that it has David Dreyer as its CFO effective March 9. Dreyer replaces Frederick D. Furry, who resigned January 31 to pursue other opportunities. Dreyer most recently served as CFO of Patient Safety Technologies.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use